(NOVC.DE) Stock Price & Overview
FRA:NOVC • DK0060534915
Current stock price
The current stock price of NOVC.DE is 86.34 EUR. Today NOVC.DE is down by -2.3%. In the past month the price decreased by -49.3%. In the past year, price decreased by -13.99%.
NOVC.DE Key Statistics
- Market Cap
- 386.277B
- P/E
- 43.17
- Fwd P/E
- 15.13
- EPS (TTM)
- 2.00
- Dividend Yield
- N/A
NOVC.DE Stock Performance
NOVC.DE Stock Chart
NOVC.DE Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to NOVC.DE. When comparing the yearly performance of all stocks, NOVC.DE is a bad performer in the overall market: 93.76% of all stocks are doing better.
NOVC.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to NOVC.DE. NOVC.DE gets an excellent profitability rating and is at the same time showing great financial health properties.
NOVC.DE Earnings
NOVC.DE Forecast & Estimates
32 analysts have analysed NOVC.DE and the average price target is 169.94 EUR. This implies a price increase of 96.83% is expected in the next year compared to the current price of 86.34.
For the next year, analysts expect an EPS growth of 96.77% and a revenue growth 27.56% for NOVC.DE
NOVC.DE Groups
Sector & Classification
NOVC.DE Financial Highlights
Over the last trailing twelve months NOVC.DE reported a non-GAAP Earnings per Share(EPS) of 2. The EPS decreased by -32.68% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 33.4% | ||
| ROA | 23.95% | ||
| ROE | 74.32% | ||
| Debt/Equity | 0.21 |
NOVC.DE Ownership
NOVC.DE Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| SAN | SANOFI | 9.77 | 199.775B | ||
| SNW | SANOFI | 9.73 | 199.244B | ||
| 1SAN | SANOFI | 9.63 | 197.264B | ||
| UNC | UCB SA | 25.16 | 50.339B | ||
| UCB | UCB SA | 26.04 | 50.281B | ||
| MRK | MERCK KGAA | 13.29 | 46.782B | ||
| BAYN | BAYER AG-REG | 8.57 | 38.693B | ||
| 1BAYN | BAYER AG-REG | 8.23 | 37.843B | ||
| IPN | IPSEN | 13.53 | 13.443B | ||
| REC | RECORDATI INDUSTRIA CHIMICA | 17.25 | 10.256B | ||
| TUB | FINANCIERE DE TUBIZE | N/A | 9.436B | ||
| VIRP | VIRBAC SA | 16.49 | 2.974B | ||
| DMP | DERMAPHARM HOLDING SE | 18.47 | 2.277B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Frankfurt Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find more growth stocks the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About NOVC.DE
Company Profile
Novo Nordisk A/S is a DK-based company operating in Pharmaceuticals industry. Novo Nordisk A/S is a global healthcare company engaged in diabetes care. The firm is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The firm operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The firm's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs. The firm's biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. The firm also offers Saxenda product to treat obesity. The company offers a range of products, including NovoLog/NovoRapid; NovoLog Mix/NovoMix; Prandin/NovoNorm; NovoSeven; Norditropin, and Vagifem. As of December 31, 2016, it marketed its products in over 180 countries. Its regional structure consists of two commercial units: North America and International Operations.
Company Info
IPO: 1974-05-17
Novo Alle 1
Bagsvaerd DK
Employees: 59337
Phone: 4544448888.0
/ NOVC.DE FAQ
What does NOVC do?
Novo Nordisk A/S is a DK-based company operating in Pharmaceuticals industry. Novo Nordisk A/S is a global healthcare company engaged in diabetes care. The firm is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The firm operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The firm's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs. The firm's biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. The firm also offers Saxenda product to treat obesity. The company offers a range of products, including NovoLog/NovoRapid; NovoLog Mix/NovoMix; Prandin/NovoNorm; NovoSeven; Norditropin, and Vagifem. As of December 31, 2016, it marketed its products in over 180 countries. Its regional structure consists of two commercial units: North America and International Operations.
What is the stock price of today?
The current stock price of NOVC.DE is 86.34 EUR. The price decreased by -2.3% in the last trading session.
What is the dividend status of ?
NOVC.DE does not pay a dividend.
What is the ChartMill technical and fundamental rating of NOVC stock?
NOVC.DE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
Where is (NOVC.DE) stock traded?
NOVC.DE stock is listed on the Frankfurt Stock Exchange exchange.
Is (NOVC.DE) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on NOVC.DE.
What is the ownership structure of (NOVC.DE)?
You can find the ownership structure of (NOVC.DE) on the Ownership tab.